Joe Lopez is an experienced professional in the field of biologics and cell therapy, currently serving as a QC Specialist 3 at CTMC, a joint venture between Resilience and MD Anderson Cancer Center, since May 2022. Previously, Joe worked as a Biologics Development Associate 3 at MD Anderson Cancer Center, conducting quality control release testing on therapeutics, and as a Senior Assay Development Associate at Bellicum Pharmaceuticals, focusing on validation assays for cell therapy products. Joe's career includes significant roles at AutoGenomics, Bristol-Myers Squibb, Medarex, and GenPharm International, contributing to the development of immunotherapies and recombinant antibodies. Joe holds a Bachelor's Degree in Chemistry from San Jose State University, obtained between 2008 and 2013.
This person is not in any offices
CTMC / A joint venture between Resilience + MD Anderson Cancer Center
Cell Therapy Manufacturing Center (CTMC) is a joint venture between Resilience and MD Anderson Cancer Center. CTMC was created to bring together the leading complex biologics manufacturing technology organization and the #1 clinical cancer center to enable innovation from academia and biotech to accelerate Cell Therapy’s impact for cancer patients.
Employees
51-200